Haleon (HLN) Receivables (2021 - 2025)
Haleon (HLN) posted Receivables of $3.0 billion for Q4 2025, up 25.76% on a QoQ basis from $2.4 billion in Q4 2024, and up 25.76% year-over-year from $2.4 billion in Q4 2024.
Haleon (HLN) Receivables (2021 - 2025) Analysis & Trends
Haleon's Receivables history runs 5 years deep, the most recent figure standing at $3.0 billion for Q4 2025.
- Quarterly Receivables rose 25.76% year-over-year to $3.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 billion (up 25.76% YoY) and the FY2025 annual result came in at $3.0 billion, changed 0.01% from the prior year.
- Receivables was $3.0 billion for Q4 2025 at Haleon, up from $2.4 billion in the prior quarter.
- Across five years, Receivables topped out at $14.6 billion in Q2 2022 and bottomed at $2.4 billion in Q4 2024.
- A 5-year average of $4.3 billion and a median of $2.7 billion in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables tumbled 82.51% — and 2025, when it rose 25.76%.
- Haleon's Receivables stood at $3.7 billion in 2021, then slumped by 31.54% to $2.5 billion in 2022, then increased by 7.09% to $2.7 billion in 2023, then declined by 12.37% to $2.4 billion in 2024, then rose by 25.76% to $3.0 billion in 2025.
- Business Quant data shows HLN's Receivables at $3.0 billion in Q4 2025, $2.4 billion in Q4 2024, and $2.7 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 2.99 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 6.46 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 312.00 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.29 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.58 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 768.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.15 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 2.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.99 Bn |
| Dec 31, 2024 | 2.38 Bn |
| Jun 30, 2024 | 2.70 Bn |
| Dec 31, 2023 | 2.72 Bn |
| Jun 30, 2023 | 2.56 Bn |
| Dec 31, 2022 | 2.54 Bn |
| Jun 30, 2022 | 14.63 Bn |
| Dec 31, 2021 | 3.71 Bn |